Kymera Therapeutics Financial Overview
Kymera Therapeutics's market cap is currently $6.65B. The company's EPS TTM is $-0.94; its P/E ratio is -23.41; Kymera Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.
